Slow Capital’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,584
Closed -$310K 123
2024
Q4
$310K Sell
21,584
-94,756
-81% -$1.5M 0.04% 115
2024
Q3
$2.63M Buy
116,340
+10,814
+10% +$224K 0.4% 77
2024
Q2
$2.05M Buy
105,526
+17,761
+20% +$465K 0.33% 85
2024
Q1
$3.29M Buy
87,765
+23,749
+37% +$1.04M 0.53% 62
2023
Q4
$3.58M Sell
64,016
-1,300
-2% -$56.6K 0.62% 49
2023
Q3
$2.69M Sell
65,316
-3,604
-5% -$187K 0.49% 63
2023
Q2
$3.85M Sell
68,920
-3,079
-4% -$167K 0.67% 36
2023
Q1
$4.02M Buy
71,999
+18,352
+34% +$857K 0.75% 34
2022
Q4
$1.95M Sell
53,647
-5,285
-9% -$173K 0.44% 79
2022
Q3
$1.68M Sell
58,932
-1,560
-3% -$59.4K 0.36% 85
2022
Q2
$2.74M Buy
60,492
+18,702
+45% +$970K 0.66% 44
2022
Q1
$3.18M Buy
41,790
+24,595
+143% +$2.15M 0.59% 43
2021
Q4
$2.56M Buy
17,195
+8,019
+87% +$1.23M 0.44% 83
2021
Q3
$1.34M Buy
9,176
+562
+7% +$96.5K 0.24% 120
2021
Q2
$1.69M Buy
8,614
+2,562
+42% +$464K 0.32% 112
2021
Q1
$1.09M Buy
6,052
+1,636
+37% +$283K 0.24% 130
2020
Q4
$626K Buy
4,416
+4,358
+7,514% +$632K 0.15% 135
2020
Q3
$7K Buy
+58
New +$6.09K ﹤0.01% 253

Other funds holding TXG

Slow Capital's TXG Position: Q1 2025 in Review

Slow Capital sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 21,584 shares — an estimated $310K sold.

Slow Capital first reported a position in TXG in Q3 2020 and held it in 18 quarters. The position peaked at $4.02M in Q1 2023. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • Slow Capital reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • Slow Capital sold 21,584 10x Genomics shares in Q1 2025, an estimated $310K.
  • Slow Capital first reported a position in 10x Genomics in Q3 2020 and held it in 18 quarters.
  • Slow Capital's 10x Genomics position peaked at $4.02M in Q1 2023.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Slow Capital's 13F filing for Q1 2025, filed 2 May 2025.